Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients

Objective. To assess the efficacy and tolerability of the association sibutramine (10–20 mg/day) and orlistat (120 mg 2-3 times a day) in the treatment of obesity in a six-month open trial. Methods. 446 overweight and obese patients who sought treatment for obesity in a private clinic were assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpern, Alfredo, Pepe, Renata B., Monegaglia, Ana Paola, Beyruti, Mônica, de Melo, Maria Edna, Mancini, Marcio C.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943097/
https://www.ncbi.nlm.nih.gov/pubmed/20871858
http://dx.doi.org/10.1155/2010/602537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943097/
https://www.ncbi.nlm.nih.gov/pubmed/20871858
http://dx.doi.org/10.1155/2010/602537

Ejemplares similares